Last reviewed · How we verify
Salmonella-IL2
At a glance
| Generic name | Salmonella-IL2 |
|---|---|
| Also known as | Saltikva |
| Sponsor | Salspera LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Saltikva for Metastatic Pancreatic Cancer (PHASE2)
- IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |